Cargando…

Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan

The public assistance system in Japan provides detailed and comprehensive livelihood support for low-income families with various needs. As one example, and the beneficiaries of the public welfare program in Japan can receive the same medical treatments as those insured of the universal public healt...

Descripción completa

Detalles Bibliográficos
Autor principal: Yuda, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259971/
https://www.ncbi.nlm.nih.gov/pubmed/35812488
http://dx.doi.org/10.3389/fpubh.2022.895679
_version_ 1784741908729298944
author Yuda, Michio
author_facet Yuda, Michio
author_sort Yuda, Michio
collection PubMed
description The public assistance system in Japan provides detailed and comprehensive livelihood support for low-income families with various needs. As one example, and the beneficiaries of the public welfare program in Japan can receive the same medical treatments as those insured of the universal public health insurance without any financial burdens. This system has greatly contributed to maintaining and improving the health of public assistance beneficiaries but may cause excessive healthcare utilization: moral hazard. This study uses a large sample taken from two nationally representative claim data for public assistance and public health insurance patients to estimate the magnitude of moral hazard effect in basic outpatient utilization. The results of the fixed-effect regression analysis utilizing the concept of pseudo panel data analysis and those of propensity score matching show that the average treatment effect of public assistance assignment on healthcare utilization is significantly positive. Specifically, public assistance assignment increases monthly healthcare expenditure by 17.5 to 22.9 percent and the monthly number of doctor visits by 23.1 to 27.8 percent, respectively. In addition, the average treatment effects on the treated are also significantly positive, suggesting that monthly healthcare expenditure significantly decreases by 22.7 to 25.0 percent and the number of visits by 27.6 to 29.7 percent, respectively, when imposing a copayment on public assistance beneficiaries. However, the estimated price elasticity based on these results is very small, approximately −0.02, indicating that the level of copayment rate has little effect on the intensive margin of outpatient healthcare utilization.
format Online
Article
Text
id pubmed-9259971
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92599712022-07-08 Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan Yuda, Michio Front Public Health Public Health The public assistance system in Japan provides detailed and comprehensive livelihood support for low-income families with various needs. As one example, and the beneficiaries of the public welfare program in Japan can receive the same medical treatments as those insured of the universal public health insurance without any financial burdens. This system has greatly contributed to maintaining and improving the health of public assistance beneficiaries but may cause excessive healthcare utilization: moral hazard. This study uses a large sample taken from two nationally representative claim data for public assistance and public health insurance patients to estimate the magnitude of moral hazard effect in basic outpatient utilization. The results of the fixed-effect regression analysis utilizing the concept of pseudo panel data analysis and those of propensity score matching show that the average treatment effect of public assistance assignment on healthcare utilization is significantly positive. Specifically, public assistance assignment increases monthly healthcare expenditure by 17.5 to 22.9 percent and the monthly number of doctor visits by 23.1 to 27.8 percent, respectively. In addition, the average treatment effects on the treated are also significantly positive, suggesting that monthly healthcare expenditure significantly decreases by 22.7 to 25.0 percent and the number of visits by 27.6 to 29.7 percent, respectively, when imposing a copayment on public assistance beneficiaries. However, the estimated price elasticity based on these results is very small, approximately −0.02, indicating that the level of copayment rate has little effect on the intensive margin of outpatient healthcare utilization. Frontiers Media S.A. 2022-06-23 /pmc/articles/PMC9259971/ /pubmed/35812488 http://dx.doi.org/10.3389/fpubh.2022.895679 Text en Copyright © 2022 Yuda. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Yuda, Michio
Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan
title Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan
title_full Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan
title_fullStr Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan
title_full_unstemmed Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan
title_short Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan
title_sort healthcare utilization under a comprehensive public welfare program: evidence from japan
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259971/
https://www.ncbi.nlm.nih.gov/pubmed/35812488
http://dx.doi.org/10.3389/fpubh.2022.895679
work_keys_str_mv AT yudamichio healthcareutilizationunderacomprehensivepublicwelfareprogramevidencefromjapan